Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Lipodystrophy”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Not applicableLooking for participantsNCT02325674
What this trial is testing

MEASuRE: Metreleptin Effectiveness And Safety Registry

Who this might be right for
Generalised LipodystrophyPartial Lipodystrophy
Amryt Pharma 100
Not applicableLooking for participantsNCT05996536
What this trial is testing

Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)

Who this might be right for
Lipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 14
Large-scale testing (Phase 3)Looking for participantsNCT06679270
What this trial is testing

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Who this might be right for
Familial Partial Lipodystrophy
Amryt Pharma 24
Testing effectiveness (Phase 2)Study completedNCT03508687
What this trial is testing

Study of Gemcabene in Adults With FPLD

Who this might be right for
Familial Partial LipodystrophyHypertriglyceridemiaFatty Liver+1 more
Elif Oral 5
Not applicableStudy completedNCT07090629
What this trial is testing

The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island.

Who this might be right for
High CholesterolLipodystrophy, Familial PartialDiabetes
Centre Hospitalier Universitaire de la Réunion 126
Not applicableWithdrawnNCT04056000
What this trial is testing

Lipodystrophy and Fat Metabolism During Exercise

Who this might be right for
HealthyLipodystrophy, Familial Partial
University of Exeter
Testing effectiveness (Phase 2)Study completedNCT03514420
What this trial is testing

Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 4
Large-scale testing (Phase 3)Not Yet RecruitingNCT07220785
What this trial is testing

Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy

Who this might be right for
Generalized Lipodystrophy
Regeneron Pharmaceuticals 28
Testing effectiveness (Phase 2)Looking for participantsNCT05470504
What this trial is testing

Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

Who this might be right for
Insulin Receptor MutationPartial Lipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Testing effectiveness (Phase 2)Study completedNCT02639286
What this trial is testing

Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension

Who this might be right for
Lipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5
Post-approval studies (Phase 4)Looking for participantsNCT06484868
What this trial is testing

Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Who this might be right for
Partial Lipodystrophy
Amryt Pharma 12
Not applicableStudy completedNCT02577952
What this trial is testing

Lipodystrophy Connect Patient Registry

Who this might be right for
Lipodystrophy
PatientCrossroads 257
Not applicableUnknownNCT06107439
What this trial is testing

Impact of Lipodystrophy on the Inflammatory State of Non-diabetic Dunnigan Reunion Island Subjects

Who this might be right for
LipodystrophyDunnigan Syndrome
Centre Hospitalier Universitaire de la Réunion 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05164341
What this trial is testing

Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL

Who this might be right for
Partial Lipodystrophy
Amryt Pharma 69
Testing effectiveness (Phase 2)Study completedNCT02430077
What this trial is testing

Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients

Who this might be right for
Familial Partial Lipodystrophy
Abhimanyu Garg 10
Large-scale testing (Phase 3)Study completedNCT00896298
What this trial is testing

Trial of Leptin Replacement Therapy in Patients With Lipodystrophy

Who this might be right for
HypoleptinemiaGeneralized LipodystrophyPartial Lipodystrophy+1 more
University of Texas Southwestern Medical Center 25
Not applicableAvailableNCT02404896
What this trial is testing

Expanded Access Metreleptin Study

Who this might be right for
Familial Partial Lipodystrophy
University of Michigan
Testing effectiveness (Phase 2)Looking for participantsNCT07091734
What this trial is testing

Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024

Who this might be right for
Lipodystrophy, Partial
University of Michigan 32
Large-scale testing (Phase 3)Ended earlyNCT02527343
What this trial is testing

The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 40
Testing effectiveness (Phase 2)Study completedNCT03262610
What this trial is testing

Setmelanotide in a Single Patient With Partial Lipodystrophy

Who this might be right for
HypertriglyceridemiaObesity
Rhythm Pharmaceuticals, Inc. 1
Load More Results